 |
|
Researchers discover link between organ transplantation and increased cancer risk
July 16, 2008PHILADELPHIA - Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk.
In the July 15, 2008, issue of Cancer Research, researchers at Harvard Medical School found in animal and laboratory experiments that the anti-rejection, immunosuppressive drug cyclosporine ramps up expression of vascular endothelial growth factor (VEGF), which signals the growth of new blood vessels that can feed tumors.
They also found that simultaneously administering an anti-VEGF therapy with cyclosporine in mice repressed this tumor growth. Several inhibitors of VEGF are already in use in human cancer therapy.
The findings could offer some good news for the 15 to 20 percent of transplant patients who develop cancer within a decade of receiving new organs, according to the study's senior investigator, Soumitro Pal, Ph.D., an assistant professor at Harvard Medical School's Transplantation Research Center at Children's Hospital in Boston.
"It may be that anti-VEGF agents given judiciously after transplantation can reduce future cancer occurrence," he said.
VEGF expression is markedly increased in patients post-transplantation, and this can aid in the development of a blood supply to a transplanted organ, helping it survive and thrive. "But once the organ has stabilized, it may be possible to lower the level of VEGF expression to prevent tumor growth," he said. "We would need to figure out how to balance benefit and risk to keep cancer at bay."
Tumors that develop after transplantation may have three potential sources: they may have pre-existed or could have been a recurrence of previous cancer - and in both of these cases, a patient's pre-transplant immune system might have kept these cancers in check - or cancer-causing viruses could have come from the donor organ. Physicians have long observed that immunosuppressive agents, such as the class of calcineurin inhibitors that includes cyclosporine, appear to promote cancer development, often in organs that are not transplanted, but the cause of this was unclear. The Harvard team tested the ability of cyclosporine to promote growth of pre-existing tumors in mice implanted with human renal (kidney) cancer cells. Mice treated with the agent formed tumors faster than untreated mice, but anti-VEGF therapy substantially reduced that excessive growth.
Digging deeper into the biological pathway of VEGF activation, the scientists found that cyclosporine activates two of the three forms of the common protein catalyst, protein kinase C, which leads to increased expression of VEGF.
"We think PKC-mediated VEGF transcriptional activation is a key component in the progression of cyclosporine-induced post-transplantation cancer," Pal said. "It is likely not the whole story, but this gives us a clue that we might be able to use existing or novel therapies to reduce cancer risk in transplanted patients."
American Association for Cancer Research
The findings could offer some good news for the 15 to 20 percent of transplant patients who develop cancer within a decade of receiving new organs, according to the study's senior investigator, Soumitro Pal, Ph.D., an assistant professor at Harvard Medical School's Transplantation Research Center at Children's Hospital in Boston.
"It may be that anti-VEGF agents given judiciously after transplantation can reduce future cancer occurrence," he said.
VEGF expression is markedly increased in patients post-transplantation, and this can aid in the development of a blood supply to a transplanted organ, helping it survive and thrive. "But once the organ has stabilized, it may be possible to lower the level of VEGF expression to prevent tumor growth," he said. "We would need to figure out how to balance benefit and risk to keep cancer at bay."
Tumors that develop after transplantation may have three potential sources: they may have pre-existed or could have been a recurrence of previous cancer - and in both of these cases, a patient's pre-transplant immune system might have kept these cancers in check - or cancer-causing viruses could have come from the donor organ. Physicians have long observed that immunosuppressive agents, such as the class of calcineurin inhibitors that includes cyclosporine, appear to promote cancer development, often in organs that are not transplanted, but the cause of this was unclear. The Harvard team tested the ability of cyclosporine to promote growth of pre-existing tumors in mice implanted with human renal (kidney) cancer cells. Mice treated with the agent formed tumors faster than untreated mice, but anti-VEGF therapy substantially reduced that excessive growth.
Digging deeper into the biological pathway of VEGF activation, the scientists found that cyclosporine activates two of the three forms of the common protein catalyst, protein kinase C, which leads to increased expression of VEGF.
"We think PKC-mediated VEGF transcriptional activation is a key component in the progression of cyclosporine-induced post-transplantation cancer," Pal said. "It is likely not the whole story, but this gives us a clue that we might be able to use existing or novel therapies to reduce cancer risk in transplanted patients."
American Association for Cancer Research
Organ Transplantation Current Events and Organ Transplantation News RSSGene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.
Switching immunosuppressants reduces cancer risk in kidney
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Prompt diagnosis of ear infections can improve outcome for organ transplant recipients
Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.
New Strategy for Inhibiting Virus Replication
Viruses need living cells for replication and production of virus progeny. Thus far, antiviral therapy primarily targets viral factors but often induces therapy resistance. New improved therapies attempt to targets cellular factors that are essential for viral replication.
Microscopic 'beads' could help create 'designer' immune cells that ignore transplanted organs
The future of organ transplantation could include microscopic beads that create "designer" immune cells to help patients tolerate their new organ, Medical College of Georgia researchers say.
CSHL scientists harness logic of 'Sudoku' math puzzle to vastly enhance genome-sequencing capability
A math-based game that has taken the world by storm with its ability to delight and puzzle may now be poised to revolutionize the fast-changing world of genome sequencing and the field of medical genetics.
TB breakthrough could lead to stronger vaccine
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine's Advance Online Publication March 1.
New surgical implant tested at U-Iowa prevents total blindness
A work accident leaves a woman blind in one eye. As she copes with the loss, within months the vision in the other, previously uninjured eye begins to blur, and the eye becomes red and inflamed.
Kidney transplant survival can be long-term for people with HIV
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed.
'Smart scaffolds' may help heal broken hearts
Imagine new treatments for heart disease or muscle loss that direct the body to repair damaged tissue rather than helping it cope with a weakened condition.
More Organ Transplantation Current Events and Organ Transplantation News Articles
 |
Organ Transplantation (Health and Medical Issues Today) by David Petechuk (Author) Every day, newspapers and television news programs present stories on the latest controversies over healthcare and medical advances, but they do not have the space to provide detailed background on the issues. Websites and weblogs provide information from activists and partisans intent on presenting their side of a story. But where can students - or even ordinary citizens - go to obtain unbiased, detailed background on the medical issues affecting their daily lives? This volume in the Health and Medical Issues Today series provides readers and researchers a balanced, in-depth introduction to the medical, scientific, legal, and cultural issues surrounding organ tranplants and its import in today's world of healthcare. Organ Transplantation is organized to provide readers with easy access... |
|
Saudi Journal of Kidney Diseases and Transplantation by Saudi Ctr Organ Transplantatio Publication is a nephrology and organ transplantation journal. | |
 |
Atlas of Organ Transplantation by Abhinav Humar (Author), Arthur J. Matas (Author), William D. Payne (Author) This book-DVD presents a picture and video atlas of organ transplantation that provides a unique and complete presentation of procedures performed by transplant surgeons today. The emphasis is on contemporary procedures, as the field has undergone significant surgical innovation in the last five to ten years. Detailed schematic diagrams and high-quality photographs of the operative procedures provide enhanced visual clarity. Written descriptions, accompanied by a video presentation with detailed narration, present realistic and complete exposure of the operative procedure. A comprehensive compilation of the majority of surgical procedures in transplant surgery, this book details the latest and most innovative procedures in one reference work. "Atlas of Organ Transplantation" is essential... |
 |
A.H.P.B.A- 2005 Surgical Spring Week /DVD:13 Also With: American Hepato-Pancreato-Biliary Association (Host) A.H.P.B.A- 2005 Surgical Spring Week /DVD:13 AHPBA/AASLD - Joint symposium: Organ allocation policy for liver transplantation . Costs and outcomes following liver transplantation in patients from large and small OPOs - Dr. James Trotter . View from a single center OPO - Dr. John P. McVicar . View from a multicenter OPO - Dr. Steven D. Colquhoun (USA) |
|
Organ Transplantation (Landes Bioscience Medical Handbook (Vademecum)) by Frank P. Stuart (Editor) Northwestern Univ., Chicago, IL. Pocket-sized manual for students, residents, and practitioners; addressing immunologic concepts, immunosuppression, organ allocation in the U.S., organ procurement organizations, transplantation, anesthesia for organ transplantation, medical problems and complications, and more. Previous edition: c2000. Softcover. | |
 |
Transplantation Ethics by Robert Veatch (Author) Three decades after the first heart transplant surgery stunned the world, organs including eyes, lungs, livers, kidneys and hearts are transplanted everyday. However, despite its routine nature - or perhaps because of it - transplantation offers enormous ethical challenges. Veatch offers a systematic account of the ethical controversies surrounding organ transplants. He structures his discussion around three major topics: the definition of death; the procurement of organs; and the allocation of organs. He addresses both fundamental questions and recently emerging issues, offering his own solutions in many instances. Complete with case studies, this book is intended for a broad cross-section of people interested in the ethics of transplantation from either the medical or public policy... |
 |
Introduction to Organ Transplantation by Nadey S. Hakim (Editor) This book provides an overview of the current status of transplant surgery for students and trainees with an interest in this field. It opens with introductory chapters on the basic science of immunobiology, the HLA system and ethics, and then examines through an organ-based structure the practice of transplantation in each major system, from skin to intestine. Issues of line-related transplantation, coordination and the role of therapeutics are also discussed. |
 |
Kidney for Sale by Owner: Human Organs, Transplantation, and the Mark by Mark J Cherry (Author) Over the past decade in the United States, nearly 6,000 people a year have died waiting for organ transplants. In 2003 alone, only 20,000 out of the 83,000 waiting for transplants received them - in anyone's eyes, a tragedy. Many of these deaths could have been prevented, and many more lives saved, were it not for the almost universal moral hand wringing over the concept of selling human organs. Bioethicist Mark Cherry explores the why of these well-intentioned misperceptions and legislation and boldly deconstructs the roadblocks that are standing in the way of restoring health to thousands of people. If most Americans accept the notion that the market is the most efficient means to distribute resources, why should body parts be excluded? Kidney for Sale by Owner contends that the market... |
 |
Legal and Ethical Aspects of Organ Transplantation by David Price (Author) Organ transplantation raises singularly difficult ethical and legal issues in its requirement for donated organs. Strategies to facilitate supply in the face of increasing demand must be ethically sound and subject to an appropriate and effective regulatory framework. Professor David Price gives a comprehensive analysis of existing laws and policies governing transplantation practices around the world. He examines the meaning of death, cadaver organ procurement policies, use of living donors, trading in human organs, experimental transplant procedures and xenotransplantation. Professor Price identifies the specific challenges in current practices and future developments. |
 |
On the List: Fixing America's Failing Organ Transplant System by Steve Farber (Author), Harlan Abrahams (Author) Two families came together in the waiting room of a Denver hospital on May 11, 2004, to await kidney transplants for loved ones. In the first operation, Gregg Farber, 32, a real estate executive, donated a kidney to his father, Steve, a 60-year-old Denver lawyer and power broker. In the second, Guatemalan refugee and landscaper Ernesto Delaroca, also 32, donated a kidney to his sister Sandra, 19, a restaurant worker. The stories of how the Farber and Delaroca families made their separate journeys to the operating room offers insight into the hazards and inequities of a cobbled-together system that each year leaves more than 98,000 gravely ill Americans on the waiting list for a life-saving transplant. Steve Farber’s experience inspired him to write On the List with Harlan Abrahams. They... |
| © 2009 BrightSurf.com |